Olga Minaeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Olga Minaeva has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Lee E. Goldstein
Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA
6 shared publications - Juliet A. Moncaster
Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA
4 shared publications - Ning Hua
Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA
3 shared publications - Douglas S. Parsons
Molecular Aging & Development Laboratory, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA; Boston University Photonics Center, Boston University, Boston, MA, USA
2 shared publications A. Yarashev
Stavropol State Medical University, neurology- neurosurgery and medical genetics, Stavropol, Russia
1 shared publication- Ali Guermazi
Department of Radiology, Boston University School of Medicine, Boston, Mass
1 shared publication
Latest Publications
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Microtubule‐associated protein tau (MAPT) in the lens of the eye in non‐transgenic and transgenic tau mutant (P301S) mice
Background: We previously discovered that Aβ accumulates in the cortical/supranuclear region of the lens in people with Alzheimer’s Disease (AD) (Goldstein et al., 2003) and Down Syndrome (DS; (Moncaster et al., 2010). We also demonstrated Aβ in the Tg2576 APP Swedish mutation AD mouse model (Moncaster et al., 2022). Another protein that is involved in AD is Microtubule‐Associated Protein Tau (MAPT). Tau is expressed in the brain and becomes hyperphosphorylated in AD eventually forming neurofibrillary tangles. Tau has previously been reported to be expressed in the mouse lens (Bai et al., 2007; Zhao et al., 2013) but the results vary depending on the mouse model. Here we investigated whether tau protein was expressed in non‐transgenic mouse lenses and in a transgenic tau mutant (P301S) mouse model. We also studied whether cataracts may develop in this P301S tau mutant mouse model.Method: P301S tau mutant transgenic and non‐transgenic mice were bred and maintained at Boston University. Breeder mice were purchased from The Jackson Laboratory, Bar Harbor, ME. Male and Female transgenic and non‐transgenic mice were sacrificed throughout their lifespan at ages 3‐12 months. Mice were perfused with phosphate buffer saline, lenses were isolated and then imaged under two different sources of light using a D70 digital Nikon camera and a custom‐adapted Zeiss stereophotomicroscope. Lenses were then snap frozen and analyzed by Western Blotting using tau antibodies.Result: P301S transgenic and non‐transgenic mouse lenses all expressed tau during their lifespan when analyzed by Western blot. P301S transgenic lenses demonstrated an additional higher molecular weight band compared to the non‐transgenic mice. No cataract phenotype was observed in transgenic or non‐transgenic mouse lenses.Conclusion: There was no overt difference in lens phenotype between the P301S transgenic and non‐transgenic mice. However, the banding pattern observed by Western blot for P301S transgenic mice compared to non‐transgenic was different. Our data suggest the P301S tau mutation affects tau processing but does not result in a cataract phenotype. Based on our current and previous results, the data suggests that Aβ may play a more significant role than tau in lens pathology in AD.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Open AccessMicrotubule‐associated protein tau (MAPT) in the lens of the eye in non‐transgenic and transgenic tau mutant (P301S) mice
Background: We previously discovered that Aβ accumulates in the cortical/supranuclear region of the lens in people with Alzheimer’s Disease (AD) (Goldstein et al., 2003) and Down Syndrome (DS; (Moncaster et al., 2010). We also demonstrated Aβ in the Tg2576 APP Swedish mutation AD mouse model (Moncaster et al., 2022). Another protein that is involved in AD is Microtubule‐Associated Protein Tau (MAPT). Tau is expressed in the brain and becomes hyperphosphorylated in AD eventually forming neurofibrillary tangles. Tau has previously been reported to be expressed in the mouse lens (Bai et al., 2007; Zhao et al., 2013) but the results vary depending on the mouse model. Here we investigated whether tau protein was expressed in non‐transgenic mouse lenses and in a transgenic tau mutant (P301S) mouse model. We also studied whether cataracts may develop in this P301S tau mutant mouse model.Method: P301S tau mutant transgenic and non‐transgenic mice were bred and maintained at Boston University. Breeder mice were purchased from The Jackson Laboratory, Bar Harbor, ME. Male and Female transgenic and non‐transgenic mice were sacrificed throughout their lifespan at ages 3‐12 months. Mice were perfused with phosphate buffer saline, lenses were isolated and then imaged under two different sources of light using a D70 digital Nikon camera and a custom‐adapted Zeiss stereophotomicroscope. Lenses were then snap frozen and analyzed by Western Blotting using tau antibodies.Result: P301S transgenic and non‐transgenic mouse lenses all expressed tau during their lifespan when analyzed by Western blot. P301S transgenic lenses demonstrated an additional higher molecular weight band compared to the non‐transgenic mice. No cataract phenotype was observed in transgenic or non‐transgenic mouse lenses.Conclusion: There was no overt difference in lens phenotype between the P301S transgenic and non‐transgenic mice. However, the banding pattern observed by Western blot for P301S transgenic mice compared to non‐transgenic was different. Our data suggest the P301S tau mutation affects tau processing but does not result in a cataract phenotype. Based on our current and previous results, the data suggests that Aβ may play a more significant role than tau in lens pathology in AD.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
MRI Markers for Detecting Accelerated Alzheimer’s Disease after Neurotrauma
Background: A history of traumatic brain injury (TBI) is linked to an earlier onset of Alzheimer’s disease (AD) (Nemetz et al., 1999). Evidence showed that the more severe the injury, the greater risk of developing AD (Johnson et al.,2010). However, systematic evaluation of in vivo MRI markers in the monitoring of AD progression after trauma is lacking. Here, we investigated the performance of various MRI markers in tracking AD progression after neurotrauma in a mouse model of AD. The following MRI sequences were investigated: dynamic contrast‐enhanced (DCE) MRI, Fluid attenuated inversion recovery (FLAIR) MRI, Quantitative Susceptibility Mapping (QSM) and diffusion MRI.Method: 3xTg‐AD mice (Jackson Laboratory, ME) were bred and maintained at Boston University. Unanesthetized mice were pretreated with a non‐sedating dose of the analgesic buprenorphine (0.2mg/kg, i.p.) prior to TBI. Male and female 3xTg‐AD mice were subjected to left‐lateral closed‐head impact injury at 10‐12 weeks of age as described in our previous work (Tagge et al., 2018). MRI data were acquired at 1 day, 3 days, 1 month and 3 months post TBI. DCE‐MRI was analyzed using in‐house software programmed in Matlab (Mathworks, MA). The volume of white matter hyperintensity was measured using manual contours in ImageJ (NIH). QSM data was analyzed using JHU/KKI QSM Toolbox (Li et al, 2019). Diffusion MRS was analyzed in DSI Studio (http://dsistudio.labsolver.org). Age, gender matched 3xTg‐AD mice without TBI were used as controls.Result: Increased blood‐brain permeability was detected by DCE‐MRI and changes of white matter susceptibility detected by QSM were observed in the subacute phase (1‐3 days) post TBI. Accelerated development of white matter hyperintensity was observed as early as 1 month post TBI.Conclusion: MRI markers provide valuable measures of the integrities of blood‐brain barrier and white matter after neurotrauma in vivo, and have the potential to facilitate the management of neurotrauma subjects with a risk of accelerated AD development.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessMRI Markers for Detecting Accelerated Alzheimer’s Disease after Neurotrauma
Background: A history of traumatic brain injury (TBI) is linked to an earlier onset of Alzheimer’s disease (AD) (Nemetz et al., 1999). Evidence showed that the more severe the injury, the greater risk of developing AD (Johnson et al.,2010). However, systematic evaluation of in vivo MRI markers in the monitoring of AD progression after trauma is lacking. Here, we investigated the performance of various MRI markers in tracking AD progression after neurotrauma in a mouse model of AD. The following MRI sequences were investigated: dynamic contrast‐enhanced (DCE) MRI, Fluid attenuated inversion recovery (FLAIR) MRI, Quantitative Susceptibility Mapping (QSM) and diffusion MRI.Method: 3xTg‐AD mice (Jackson Laboratory, ME) were bred and maintained at Boston University. Unanesthetized mice were pretreated with a non‐sedating dose of the analgesic buprenorphine (0.2mg/kg, i.p.) prior to TBI. Male and female 3xTg‐AD mice were subjected to left‐lateral closed‐head impact injury at 10‐12 weeks of age as described in our previous work (Tagge et al., 2018). MRI data were acquired at 1 day, 3 days, 1 month and 3 months post TBI. DCE‐MRI was analyzed using in‐house software programmed in Matlab (Mathworks, MA). The volume of white matter hyperintensity was measured using manual contours in ImageJ (NIH). QSM data was analyzed using JHU/KKI QSM Toolbox (Li et al, 2019). Diffusion MRS was analyzed in DSI Studio (http://dsistudio.labsolver.org). Age, gender matched 3xTg‐AD mice without TBI were used as controls.Result: Increased blood‐brain permeability was detected by DCE‐MRI and changes of white matter susceptibility detected by QSM were observed in the subacute phase (1‐3 days) post TBI. Accelerated development of white matter hyperintensity was observed as early as 1 month post TBI.Conclusion: MRI markers provide valuable measures of the integrities of blood‐brain barrier and white matter after neurotrauma in vivo, and have the potential to facilitate the management of neurotrauma subjects with a risk of accelerated AD development.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Molecular activation of gliovascular signaling precedes blood‐brain barrier disruption and neuronal loss in a mouse model of tauopathy
Background: Increasing evidence points to disruption of the blood‐brain barrier (BBB) as an inciting event in the pathogenesis of Alzheimer’s disease. The contribution of tau‐mediated pathways driving blood‐brain dysfunction are comparatively understudied.Method: Using the P301S mouse model of tauopathy, we employed dynamic contrast enhanced MRI (DCE‐MRI) and quantitative spatial analysis using gadolinium‐based mass spectrometry imaging to demonstrate widespread BBB dysfunction in late stage tauopathy. To identify molecular pathways regulating intercellular signaling between neurons and gliovascular support cells that are dysregulated in advance of BBB disruption, we developed a cell‐specific viral approach for transcriptional profiling of novel pathways within the multicellular environment of the neurovascular unit (NVU) in tauopathy. Viral constructs using cell‐type specific promoters (hSynapsin, GFAP, or PDGFRb) to drive expression of antigen‐tagged ribosomes (TRAP) were used to study variance in spatial and temporal gene expression patterns in NVU cell types in P301S transgenic mice prior to widespread BBB disruption.Result: Regional disruption of BBB integrity involving the hippocampus, lateral temporal, and frontal cortices is prominent in 11 month‐old P301S mice. Cell‐specific profiling of early symptomatic 6 month‐old P301S mice identified a defined gene expression profile antecedent to BBB disruption in NVU cells comprised of 29 shared and 3299 unique genes across all cell types. In this early symptomatic stage of tauopathy, pericytes (1021 genes) and astrocytes (1717 genes) were remarkably more transcriptionally active than neurons (561 genes). Gene ontology analysis indicates that multiple molecular programs driving neuronal differentiation, neurite outgrowth, and synaptogenesis are expressed in gliovascular cells in the prodromal stage.Conclusion: The specific and temporally regulated coordination of pathways in pericytes and astrocytes in advance of BBB dysfunction implicates the neurovascular unit as a potential driver in the development of tauopathy. This suggests a paradigm exists for gliovascular rescue of neurodegeneration and implicates numerous novel perivascular molecular pathways in the pathogenesis of tauopathy and Alzheimer’s disease.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Open AccessMolecular activation of gliovascular signaling precedes blood‐brain barrier disruption and neuronal loss in a mouse model of tauopathy
Background: Increasing evidence points to disruption of the blood‐brain barrier (BBB) as an inciting event in the pathogenesis of Alzheimer’s disease. The contribution of tau‐mediated pathways driving blood‐brain dysfunction are comparatively understudied.Method: Using the P301S mouse model of tauopathy, we employed dynamic contrast enhanced MRI (DCE‐MRI) and quantitative spatial analysis using gadolinium‐based mass spectrometry imaging to demonstrate widespread BBB dysfunction in late stage tauopathy. To identify molecular pathways regulating intercellular signaling between neurons and gliovascular support cells that are dysregulated in advance of BBB disruption, we developed a cell‐specific viral approach for transcriptional profiling of novel pathways within the multicellular environment of the neurovascular unit (NVU) in tauopathy. Viral constructs using cell‐type specific promoters (hSynapsin, GFAP, or PDGFRb) to drive expression of antigen‐tagged ribosomes (TRAP) were used to study variance in spatial and temporal gene expression patterns in NVU cell types in P301S transgenic mice prior to widespread BBB disruption.Result: Regional disruption of BBB integrity involving the hippocampus, lateral temporal, and frontal cortices is prominent in 11 month‐old P301S mice. Cell‐specific profiling of early symptomatic 6 month‐old P301S mice identified a defined gene expression profile antecedent to BBB disruption in NVU cells comprised of 29 shared and 3299 unique genes across all cell types. In this early symptomatic stage of tauopathy, pericytes (1021 genes) and astrocytes (1717 genes) were remarkably more transcriptionally active than neurons (561 genes). Gene ontology analysis indicates that multiple molecular programs driving neuronal differentiation, neurite outgrowth, and synaptogenesis are expressed in gliovascular cells in the prodromal stage.Conclusion: The specific and temporally regulated coordination of pathways in pericytes and astrocytes in advance of BBB dysfunction implicates the neurovascular unit as a potential driver in the development of tauopathy. This suggests a paradigm exists for gliovascular rescue of neurodegeneration and implicates numerous novel perivascular molecular pathways in the pathogenesis of tauopathy and Alzheimer’s disease.
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 244-251
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry
Gadolinium retention in the brain measured with MRI longitudinal relaxation rate mapping and laser ablation inductively coupled plasma mass spectrometry yielded different results, indicating that s... Background T1-weighted MRI and quantitative longitudinal relaxation rate (R1) mapping have been used to evaluate gadolinium retention in the brain after gadolinium-based contrast agent (GBCA) admin...
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 244-251
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry
Gadolinium retention in the brain measured with MRI longitudinal relaxation rate mapping and laser ablation inductively coupled plasma mass spectrometry yielded different results, indicating that s... Background T1-weighted MRI and quantitative longitudinal relaxation rate (R1) mapping have been used to evaluate gadolinium retention in the brain after gadolinium-based contrast agent (GBCA) admin...
- Open Access
- 21 February 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 221, 108974
Alzheimer's disease amyloid-β pathology in the lens of the eye
- 21 February 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 221, 108974
Open AccessAlzheimer's disease amyloid-β pathology in the lens of the eye
- Open Access
- 16 September 2020
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 75 (9) , e53-e62
In Vivo Quasi-Elastic Light Scattering Eye Scanner Detects Molecular Aging in Humans
The absence of clinical tools to evaluate individual variation in the pace of aging represents a major impediment to understanding aging and maximizing health throughout life. The human lens is an ideal tissue for quantitative assessment of molecular aging in vivo. Long-lived proteins in lens fiber cells are expressed during fetal life, do not undergo turnover, accumulate molecular alterations throughout life, and are optically accessible in vivo. We used quasi-elastic light scattering (QLS) to measure age-dependent signals in lenses of healthy human subjects. Age-dependent QLS signal changes detected in vivo recapitulated time-dependent changes in hydrodynamic radius, protein polydispersity, and supramolecular order of human lens proteins during long-term incubation (~1 year) and in response to sustained oxidation (~2.5 months) in vitro. Our findings demonstrate that QLS analysis of human lens proteins provides a practical technique for noninvasive assessment of molecular aging in vivo.
- 16 September 2020
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 75 (9) , e53-e62
Open AccessIn Vivo Quasi-Elastic Light Scattering Eye Scanner Detects Molecular Aging in Humans
The absence of clinical tools to evaluate individual variation in the pace of aging represents a major impediment to understanding aging and maximizing health throughout life. The human lens is an ideal tissue for quantitative assessment of molecular aging in vivo. Long-lived proteins in lens fiber cells are expressed during fetal life, do not undergo turnover, accumulate molecular alterations throughout life, and are optically accessible in vivo. We used quasi-elastic light scattering (QLS) to measure age-dependent signals in lenses of healthy human subjects. Age-dependent QLS signal changes detected in vivo recapitulated time-dependent changes in hydrodynamic radius, protein polydispersity, and supramolecular order of human lens proteins during long-term incubation (~1 year) and in response to sustained oxidation (~2.5 months) in vitro. Our findings demonstrate that QLS analysis of human lens proteins provides a practical technique for noninvasive assessment of molecular aging in vivo.
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 287
Cerebrovascular disorders in patients with essential arterial hypotension
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 287
Cerebrovascular disorders in patients with essential arterial hypotension